| |
| |
|
| Insider
Information: |
Robb Gary Charles |
| Relationship: |
|
| City: |
Menlo Park |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
28,941 |
|
|
Indirect Shares
|
25,100 |
|
|
| Direct
Value |
$944,634 |
|
|
|
Indirect Value
|
$819,264 |
|
|
| Total
Shares |
54,041 |
|
|
| Total
Value |
$1,763,898 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
18
|
|
Stock
price went up :
|
0
|
13
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.6
|
| Percentage
Gain/Loss : |
0.0%
|
 96.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corcept Therapeutics Inc |
CORT |
|
2024-06-04 |
28,941 |
2024-06-04 |
25,100 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-12-12 |
4 |
OE |
$1.92 |
$48,000 |
D/D |
25,000 |
21,858 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-09-19 |
4 |
S |
$32.74 |
$163,677 |
D/D |
(5,000) |
21,996 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-01 |
4 |
A |
$0.00 |
$16,569 |
D/D |
1,276 |
22,771 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2024-06-03 |
4 |
A |
$0.00 |
$56,903 |
D/D |
3,636 |
23,115 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-07-06 |
4 |
AS |
$26.00 |
$1,170,000 |
D/D |
(45,000) |
24,123 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-06-01 |
4 |
A |
$0.00 |
$48,030 |
D/D |
4,182 |
24,179 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-11-18 |
4 |
S |
$26.43 |
$354,188 |
D/D |
(13,401) |
26,143 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-09-14 |
4 |
D |
$33.80 |
$270,265 |
D/D |
(7,996) |
26,996 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-05 |
4 |
S |
$26.27 |
$36,277 |
D/D |
(1,381) |
27,602 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2024-06-04 |
4 |
D |
$32.87 |
$268,679 |
D/D |
(8,174) |
28,941 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-04 |
4 |
D |
$26.26 |
$230,773 |
D/D |
(8,788) |
28,983 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2024-05-28 |
4 |
OE |
$3.29 |
$36,190 |
D/D |
11,000 |
31,203 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-05-09 |
4 |
S |
$23.87 |
$716,100 |
D/D |
(30,000) |
33,997 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-09-14 |
4 |
OE |
$3.29 |
$45,938 |
D/D |
13,963 |
34,992 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-05-19 |
4 |
S |
$19.57 |
$119,928 |
D/D |
(6,127) |
36,446 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2024-06-04 |
4 |
OE |
$3.29 |
$46,060 |
D/D |
14,000 |
37,115 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-12-04 |
4 |
OE |
$3.29 |
$49,350 |
D/D |
15,000 |
37,771 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-12-09 |
4 |
OE |
$1.92 |
$57,600 |
D/D |
30,000 |
38,025 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-11-17 |
4 |
S |
$26.06 |
$260,600 |
D/D |
(10,000) |
39,544 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-05-18 |
4 |
S |
$19.55 |
$2,502 |
D/D |
(128) |
42,573 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-05-17 |
4 |
S |
$19.55 |
$561,965 |
D/D |
(28,745) |
42,701 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-09-07 |
4 |
S |
$26.06 |
$1,303,000 |
D/D |
(50,000) |
49,544 |
0 |
% |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2023-05-05 |
4 |
D |
$24.07 |
$1,458,305 |
D/D |
(60,586) |
63,997 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-07-06 |
4 |
OE |
$2.08 |
$67,968 |
D/D |
32,677 |
69,123 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Business Officer |
• – – |
2022-03-18 |
4 |
AS |
$24.67 |
$123,054 |
D/D |
(4,988) |
71,446 |
0 |
% |
|
65 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
